🔗 Share this article

Chancellor Reeves has announced she is preparing "specific action to address cost of living pressures" in next month's Budget.

During an interview with media outlets, she noted that lowering inflation is a joint responsibility of both the government and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 developed nations this calendar year and next.

Potential Utility Cost Measures

Reports indicate the administration could intervene to bring down utility costs, for instance by slashing the present 5% level of VAT charged on energy supplies.

Another approach is to lower some of the government charges currently added to bills.

Fiscal Constraints and Expert Expectations

The government will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much room there is for such measures.

The expectation from most analysts is that Reeves will have to declare tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Previously on the same day, estimates showed there was a £22 billion deficit for the chancellor to fill, which is at the more modest range of forecasts.

"There's a shared task between the Bank of England and the administration to bear down further on some of the drivers of inflation," Reeves informed reporters in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While much of the attention has been on probable tax rises, the chancellor said the latest figures from the fiscal watchdog had not altered her commitment to campaign commitments not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with increasing international and trade tensions for the fiscal tax moves, likely to be focused on those "most able to pay."

International Economic Disputes

Commenting on worries about the UK's economic relations with China she said: "Our security interests invariably take priority."

Last week's announcement by China to strengthen export controls on critical minerals and other materials that are crucial for high-technology manufacturing led American leader Donald Trump to threaten an further 100% tariff on imports from the Asian country, increasing the possibility of an all-out commercial conflict between the two global powers.

The American finance chief described China's move "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to join its conflict with China, the Chancellor said she was "very concerned" by China's measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and causes additional obstacles."

"In my view there are fields where we should address China, but there are also important prospects to sell into China's economy, including banking sector and other areas of the economic system. We've got to get that balance right."

The chancellor also confirmed she was working with G7 counterparts "on our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also recognized that the cost the NHS spends on drugs could increase as a consequence of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning investments in the UK, with several attributing the low prices they are getting.

Last month, the government science advisor said the cost the health service spends on medicines would must go up to stop businesses and pharmaceutical investment departing from the United Kingdom.

Reeves informed the BBC: "It has been observed as a result of the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the way that they are in other European countries."

"The objective is to guarantee that patients getting treatment from the National Health Service are able to access the finest life-saving treatments in the world. And so we are looking at these issues, and... seeking to secure additional funding into the UK."